T McCarthy1. Show Affiliations » 1. Chief Executive Officer & Managing Director, Spinifex Pharmaceuticals, Victoria, Australia.
Abstract
Entities: Chemical Disease
Mesh: See more » Administration, OralAngiotensin II Type 2 Receptor Blockers/administration & dosageBenzhydryl Compounds/administration & dosageClinical Trials, Phase II as TopicDouble-Blind MethodFemaleHumansIsoquinolines/administration & dosageMaleMulticenter Studies as TopicNeuralgia, Postherpetic/drug therapyPain Measurement
Substances: See more » Angiotensin II Type 2 Receptor BlockersBenzhydryl CompoundsEMA400Isoquinolines
Year: 2014 PMID: 25269730 DOI: 10.1111/jns.12080_4
Source DB: PubMed Journal: J Peripher Nerv Syst ISSN: 1085-9489 Impact factor: 3.494